|
Tobacco Use
| | | |
|
Opiate Treatment Index (OTI, quantity/frequency) [14]
|
√
|
√
|
√
|
|
Point Prevalence and Continuous Abstinence
|
√
|
√
|
√
|
|
Readiness to Quit Smoking [15]
|
√
|
-
|
-
|
|
Fagerstrom Test for Nicotine Dependence [16]
|
√
|
√
|
√
|
|
Expired Carbon Monoxide
|
√
|
√
|
√
|
|
Minnesota Nicotine Withdrawal Scale (MNWS-R)[17]
|
√
|
√
|
√
|
|
Physical Activity
| | | |
|
Readiness to change physical activity [18]
|
√
|
-
|
-
|
|
Physical activity screen (past week)
|
√
|
√
|
√
|
|
Average minutes walking per week
|
√
|
√
|
√
|
|
International Physical Activity Questionnaire [19]
|
√
|
√
|
√
|
|
Dietary Habits
| | | |
|
Readiness to change eating habits
|
√
|
-
|
-
|
|
24-hour recall of eating patterns
|
√
|
√
|
√
|
|
Other CVD Risk Factors
| | | |
|
OTI- alcohol and cannabis
|
√
|
√
|
√
|
|
Beck Depression Inventory - II [20]
|
√
|
√
|
√
|
|
Brief Symptom Inventory [21]
|
√
|
√
|
√
|
|
Body mass index (height, weight)
|
√
|
√
|
√
|
|
Waist-hip ratio (cms)
|
√
|
√
|
√
|
|
Auscultatory Blood pressure
|
√
|
√
|
√
|
|
Fingerprick Blood Tests (glucose, cholesterol, lipids)
|
√
|
√
|
√
|
|
Treatment and Service Utilisation [22]
|
√
|
√
|
√
|
|
Diagnosis of psychosis and Symptom Measure
| | | |
|
Brief Psychiatric Rating Scale [23]
|
√
|
√
|
√
|
|
Mini International Neuropsychiatric Interview [22]
|
√
|
-
|
-
|
|
Functioning
| | | |
|
Global Assessment of Functioning [24]
|
√
|
√
|
√
|
|
Medical Outcome Survey SF-36 [25]
|
√
|
√
|
√
|
|
Quality of Life Scale [26]
|
√
|
√
|
√
|
|
Impact of Weight on Quality of Life Questionnaire [27]
|
√
|
√
|
√
|
|
Therapeutic Alliance & Intervention Satisfaction [28]
|
-
|
√
|
-
|
